These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 11236030

  • 21. Non-Hodgkin's lymphomas: understanding monoclonal antibody therapy.
    Hendrix C.
    ONS News; 2006; 21(8 Suppl):19-20. PubMed ID: 16925135
    [No Abstract] [Full Text] [Related]

  • 22. Remission of human breast cancer xenografts on therapy with humanized monoclonal antibody to HER-2 receptor and DNA-reactive drugs.
    Pietras RJ, Pegram MD, Finn RS, Maneval DA, Slamon DJ.
    Oncogene; 1998 Oct 29; 17(17):2235-49. PubMed ID: 9811454
    [Abstract] [Full Text] [Related]

  • 23. Dose-fractionated radioimmunotherapy in non-Hodgkin's lymphoma using DOTA-conjugated, 90Y-radiolabeled, humanized anti-CD22 monoclonal antibody, epratuzumab.
    Lindén O, Hindorf C, Cavallin-Ståhl E, Wegener WA, Goldenberg DM, Horne H, Ohlsson T, Stenberg L, Strand SE, Tennvall J.
    Clin Cancer Res; 2005 Jul 15; 11(14):5215-22. PubMed ID: 16033839
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Radioimmunotherapy in the treatment of non-Hodgkin's lymphoma.
    Kaminski MS, Armitage JO.
    J Natl Compr Canc Netw; 2004 Sep 15; 2 Suppl 3():S-54-8. PubMed ID: 23570101
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [Immunoscintigraphy and radioimmunotherapy of cancer using monoclonal antibodies].
    Oriuchi N.
    Gan To Kagaku Ryoho; 1999 May 15; 26(6):762-7. PubMed ID: 10410144
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. ASCO 2011: broadening the horizons of cancer research.
    Crane K.
    J Natl Cancer Inst; 2011 Jul 06; 103(13):999-1001. PubMed ID: 21693729
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Radioimmunoconjugates for treating cancer: recent advances and current opportunities.
    Bourgeois M, Bailly C, Frindel M, Guerard F, Chérel M, Faivre-Chauvet A, Kraeber-Bodéré F, Bodet-Milin C.
    Expert Opin Biol Ther; 2017 Jul 06; 17(7):813-819. PubMed ID: 28438082
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Monoclonal antibody therapy in the treatment of non-Hodgkin lymphoma.
    McCune SL, Gockerman JP, Rizzieri DA.
    JAMA; 2001 Sep 12; 286(10):1149-52. PubMed ID: 11559240
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [Hypersensitivity reactions to cancer chemotherapeutic agents].
    Sato A, Sakashita A, Taguchi S.
    Gan To Kagaku Ryoho; 2003 Jun 12; 30(6):793-800. PubMed ID: 12852346
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.